These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31974125)

  • 1. Duchenne muscular dystrophy.
    Fox H; Millington L; Mahabeer I; van Ruiten H
    BMJ; 2020 Jan; 368():l7012. PubMed ID: 31974125
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed diagnosis of Duchenne muscular dystrophy.
    Mohamed K; Appleton R; Nicolaides P
    Eur J Paediatr Neurol; 2000; 4(5):219-23. PubMed ID: 11030068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should creatine kinase be checked in all boys presenting with speech delay?
    Lundy CT; Doherty GM; Hicks EM
    Arch Dis Child; 2007 Jul; 92(7):647-9. PubMed ID: 17588982
    [No Abstract]   [Full Text] [Related]  

  • 4. Muscular dystrophy: Are we looking for subtle signs?
    Biswas A
    Arch Dis Child; 2018 May; 103(5):522. PubMed ID: 29222177
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural History of Serum Enzyme Levels in Duchenne Muscular Dystrophy and Implications for Clinical Practice.
    Rodríguez-Cruz M; Almeida-Becerril T; Atilano-Miguel S; Cárdenas-Conejo A; Bernabe-García M
    Am J Phys Med Rehabil; 2020 Dec; 99(12):1121-1128. PubMed ID: 32520799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Duchenne muscular dystrophy].
    Meißner T
    MMW Fortschr Med; 2015 Jul; 157(13):81. PubMed ID: 26206053
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study.
    Felber S; Skladal D; Wyss M; Kremser C; Koller A; Sperl W
    Neurol Res; 2000 Mar; 22(2):145-50. PubMed ID: 10763500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early diagnosis of Duchenne muscular dystrophy by means of non selective neonatal screening].
    Martín Fernandez-Mayoralas D; San Antonio-Arce V; Campos-Castelló J
    Rev Neurol; 2002 Sep 16-30; 35(6):595-6. PubMed ID: 12389180
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of Treatment Effect With Multiple Outcomes in 2 Clinical Trials of Patients With Duchenne Muscular Dystrophy.
    Li D; McDonald CM; Elfring GL; Souza M; McIntosh J; Kim DH; Wei LJ
    JAMA Netw Open; 2020 Feb; 3(2):e1921306. PubMed ID: 32058550
    [No Abstract]   [Full Text] [Related]  

  • 10. Becker muscular dystrophy in a patient with Hodgkin's disease.
    Cereda S; Cefalo G; Terenziani M; Catania S; Fossati-Bellani F
    J Pediatr Hematol Oncol; 2004 Jan; 26(1):72-3. PubMed ID: 14707720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTC124, nonsense mutations and Duchenne muscular dystrophy.
    Wilton S
    Neuromuscul Disord; 2007 Oct; 17(9-10):719-20. PubMed ID: 17952895
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of Duchenne muscular dystrophy (DMD) for the pediatricians in the community.
    Verma S; Anziska Y; Cracco J
    Clin Pediatr (Phila); 2010 Nov; 49(11):1011-7. PubMed ID: 20724320
    [No Abstract]   [Full Text] [Related]  

  • 13. EMA reconsiders 'read-through' drug against Duchenne muscular dystrophy following appeal.
    Mullard A
    Nat Biotechnol; 2014 Aug; 32(8):706. PubMed ID: 25101726
    [No Abstract]   [Full Text] [Related]  

  • 14. [Duchenne muscular dystrophy born prematurely showed normal CK value until 35 weeks of gestation age].
    Morisawa T; Yagi M; Yoshii K; Takeshima Y; Matsuo M
    No To Hattatsu; 2004 Jul; 36(4):342-3. PubMed ID: 15272621
    [No Abstract]   [Full Text] [Related]  

  • 15. 50 years ago in the Journal of Pediatrics: the use of serum creatine phosphokinase and other serum enzymes in the diagnosis of progressive muscular dystrophy.
    Proud CM
    J Pediatr; 2013 Dec; 163(6):1656. PubMed ID: 24274203
    [No Abstract]   [Full Text] [Related]  

  • 16. Corticosteroid therapy for duchenne muscular dystrophy: improvement of psychomotor function.
    Sato Y; Yamauchi A; Urano M; Kondo E; Saito K
    Pediatr Neurol; 2014 Jan; 50(1):31-7. PubMed ID: 24138948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Year in review 2019: Neuromuscular diseases.
    Birnkrant DJ; Black JB
    Pediatr Pulmonol; 2020 Oct; 55(10):2542-2546. PubMed ID: 32691988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 50 Years Ago in The Journal of Pediatrics: An Assessment of the Creatine Kinase Test in the Detection of Carriers of Duchenne Muscular Dystrophy.
    Cardon MW
    J Pediatr; 2017 Jul; 186():63. PubMed ID: 28648283
    [No Abstract]   [Full Text] [Related]  

  • 19. European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene.
    Haas M; Vlcek V; Balabanov P; Salmonson T; Bakchine S; Markey G; Weise M; Schlosser-Weber G; Brohmann H; Yerro CP; Mendizabal MR; Stoyanova-Beninska V; Hillege HL
    Neuromuscul Disord; 2015 Jan; 25(1):5-13. PubMed ID: 25497400
    [No Abstract]   [Full Text] [Related]  

  • 20. Duchenne drug clings on for FDA nod.
    Nat Biotechnol; 2017 Nov; 35(11):999. PubMed ID: 29121019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.